Century Therapeutics IPSC
NASDAQ IPSC
$1.61 -0.10 (-5.85%)
At close: Oct 1, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Selling, General & Administrative (2020 - 2026)

Updated

Century Therapeutics (IPSC) recorded Selling, General & Administrative of $5.79 million in Q2 2026, down 25.9% from $7.81 million a year earlier and down 12.0% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a TTM basis, Century Therapeutics' Selling, General & Administrative came in at $20.16 million as of Jun 30, 2026, down 37.6% year-over-year; for FY2025, it was $24 million, down 27.6% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $33.16 million in FY2024 (-4.5%), $34.71 million in FY2023 (+8.9%), $31.86 million in FY2022 (+65.6%) and $19.24 million in FY2021 (+102.6%).
  • Quarterly Selling, General & Administrative has ranged from $956,000 in Q4 2025 to $8.99 million in Q3 2023 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative has declined for eight consecutive quarters, with an average decline of 22.5% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 171.5% in Q1 2022, against a decline of 87.7% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.58 million (Q1 2026), $956,000 (Q4 2025) and $6.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Century Therapeutics 308.74 Mn -195.64 Mn - 5.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.79 Mn
Mar 31, 2026 6.58 Mn
Dec 31, 2025 956,000.00
Sep 30, 2025 6.84 Mn
Jun 30, 2025 7.81 Mn
Mar 31, 2025 8.41 Mn
Dec 31, 2024 7.76 Mn
Sep 30, 2024 8.35 Mn
Jun 30, 2024 8.31 Mn
Mar 31, 2024 8.74 Mn
Dec 31, 2023 8.59 Mn
Sep 30, 2023 8.99 Mn
Jun 30, 2023 8.23 Mn
Mar 31, 2023 8.90 Mn
Dec 31, 2022 8.24 Mn
Sep 30, 2022 8.06 Mn
Jun 30, 2022 8.25 Mn
Mar 31, 2022 7.30 Mn
Dec 31, 2021 6.18 Mn
Sep 30, 2021 6.28 Mn
API Access

Century Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IPSC&period=max&api_key=YOUR_API_KEY